Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Analysts' Corner
NEW YORK, October 23, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Analysts' Corner announced new research reports highlighting CR Bard Inc. (NYSE: BCR), Cerner Corporation (NASDAQ: CERN), Universal Health Services Inc. (NYSE: UHS), Mettler-Toledo International, Inc. (NYSE: MTD), and PAREXEL International Corporation (NASDAQ: PRXL). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
CR Bard Inc. Research Report
On October 9, 2013, CR Bard Inc. (Bard) announced that the Company's Board of Directors has approved a regular quarterly dividend of $0.21 per share on the Company's common stock, which will be payable on November 1, 2013, to shareholders of record at the close of business on October 21, 2013. According to the Company, the current indicated annual dividend rate is $0.84 per share. The Full Research Report on CR Bard Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/141e_BCR]
Cerner Corporation Research Report
On October 11, 2013, Cerner Corporation (Cerner) reported that the Company along with CHE Trinity Health has together received the 2013 Collaboration Award from the College of Healthcare Information Management Executives (CHIME). According to the Company, for the past two and a half years, Cerner, and the Trinity Health division of the now-merged CHE Trinity Health have worked together to reduce, detect, and respond to severe blood conditions that can lead to organ failure and death, and the partners have managed to save the lives of more than 500 patients infected with sepsis in at least 23 acute-care hospitals. Cerner President, Zane Burke, stated, "We're very proud of the work we've done with CHE Trinity to reduce sepsis mortality. Working alongside a great partner CHE Trinity allows us an opportunity to innovate solving hard problems in health care. Through our collaboration, we're using evidence-based medicine to drive better outcomes and save lives." The Full Research Report on Cerner Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/83ac_CERN]
Universal Health Services Inc. Research Report
On October 16, 2013, Universal Health Services Inc. (Universal Health Services) announced that it will report its Q3 2013 financial results, on Tuesday, October 29, 2013, after the market hours. The Company informed that it will also host a conference call on the following day, Wednesday, October 30, 2013, at 10:00 a.m. ET, which will be broadcast live on the Company's website. The company added that a replay of the call will also be available following the conclusion of the live call for one full year. The Full Research Report on Universal Health Services Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/7d77_UHS]
Mettler-Toledo International, Inc. Research Report
On October 11, 2013, Mettler-Toledo International, Inc. (Mettler Toledo) announced that the Company is installing modern touchscreen scales from its UC Evo Line in over 200 Ziyan branches in the Shanghai area, following Ziyan's - a Chinese fast-food chain, decision to invest in the Company's weighing technology. According to the Company, the hardware of these counter scales is based on the UC-HTT-M model, and they have a 12-inch customer display in addition to an easy-to-use touchscreen interface for employees. Tan Tingwei, Executive Assistant at Ziyan, commented, "The use of the Evo scales has brought new vitality in Ziyan's operation and management. The biggest beneficiaries are our customers. METTLER TOLEDO provides weighing, billing and checkout solutions for a better customer experience. Evo Line scales also feature a user friendly interface that is easily operated by store staff. The scales' stability and reliability ensures that staff members can provide professional service to customers, thus improving store sales." Mettler Toledo's Head of Division Retail Marketing, Julia Obstfelder, said, "As a globally active company, we support our customers with internationally scalable and replicable solutions. Meanwhile, we also have excellent knowledge of local markets and the relevant requirements - such as calibration regulations or pricing and weight-labeling legislation - and always optimally align our products and services with those needs." The Full Research Report on Mettler-Toledo International, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/ac69_MTD]
PAREXEL International Corporation Research Report
On October 9, 2013, PAREXEL International Corporation's (PAREXEL) subsidiary Perceptive Informatics, along with Fujitsu Systems West Limited (FWEST), announced a technology partnership to improve clinical trial data management in Japan. The Company stated that through the collaboration, the two companies have integrated Perceptive's ClinPhone Randomization and Trial Supply Management (RTSM) solution and Fujitsu's DDworks 21™ Clinical Trial Management System (CTMS) and the new offering automatically transfers data from ClinPhoneRTSM into DDworks 21™. The Company added that apart from eliminating manual data entry, it also makes study logistical information immediately available for proactive decision making. Graham Bunn, Vice President of Partnerships, Perceptive Informatics stated, "Clinical trial management is often hindered by complex, time-consuming, manual processes for collecting, aggregating and rationalizing data. Integrating our industry-leading technologies will replace fragmented methods for capturing and leveraging data. By streamlining these processes, clients can conduct clinical trials more efficiently." The Full Research Report on PAREXEL International Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/067b_PRXL]
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
©2012 PR Newswire. All Rights Reserved.